SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Vascular Biogenics Q1 EPS $(0.12) Beats $(0.13) Estimate

Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 20 percent increase over losses of $(0.15) per share from

05/11/2021 07:21
Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 20 percent increase over losses of $(0.15) per share from the same period last year.